Why the study?
People living with COPD have a heightened risk of CVD beyond predicted risk, necessitating validation and revision of risk scoring tools for accurate prediction.
Does the QRISK3 tool accurately predict the risk of cardiovascular events in patients with COPD?
Does the QRISK3 tool accurately predict the risk of cardiovascular events in patients with COPD?
QRISK3 significantly underestimates the 10-year cardiovascular risk in patients with COPD, especially in younger individuals, indicating a need for revised risk scoring tools.
Alerts clinicians to possible QRISK3 underestimation in younger COPD patients; leaves open whether COPD-specific recalibration improves stratification.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Amegadzie et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: